RECRUITING

Investigating Changes in Premonitory Urges During Habit Reversal Training for Tics

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The primary aim of this study is to learn more about premonitory urges (PU) when using Habit Reversal Training (HRT) to treat tics. The main focus of this study is to investigate if and when PU change during tic treatment sessions and between tic treatment sessions. Participants will: * Attend 5 study visits (approximately 1 to 1.5 hours each) for an intake, habit reversal training for 3 separate tics, and a post assessment * Attend 5 practice sessions (approximately 30 minutes each) over a week for 3 weeks (total 15 practice sessions) * Study visits and practice sessions will take place in person and online via secure videoconference

Official Title

Investigating Changes in Premonitory Urges During Habit Reversal Training

Quick Facts

Study Start:2025-02
Study Completion:2026-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06825520

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:10 Years to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. 1. present with at least three motor and/or vocal tics and are interested in receiving treatment,
  2. 2. report experiencing a PU for each of their target tics with a minimum rating of a 4/8 on a subjective rating (i.e., the Urge Thermometer; Silverman \& Albano, 1996) for each tic,
  3. 3. the targeted tics occur, on average, at least once per minute during a 10-minute direct observation,
  4. 4. are between the ages of 10 and 17
  5. 5. the patient has no planned changes in medication initiation or dosage during their study participation period.
  1. 1. the presence of any comorbid conditions that are considered a primary treatment concern and/or could interfere with study participation or treatment (i.e., unmanaged ADHD, OCD, anxiety),
  2. 2. have previously engaged in CBIT or HRT for more than 2 sessions,
  3. 3. a Yale Global Tic Severity Score of 40+ (or 20+ if they present with a primary motor or vocal tic disorder),
  4. 4. suspected (based on clinical presentation) that the tics are better attributed to functional neurological symptom disorder per DSM-5-TR criteria (APA, 2022).

Contacts and Locations

Study Contact

Emily I Braley, MS
CONTACT
801-585-7114
theticlab@utah.edu
Michael Himle, PhD
CONTACT
801-581-7529
michael.himle@utah.edu

Study Locations (Sites)

University of Utah
Salt Lake City, Utah, 84112
United States

Collaborators and Investigators

Sponsor: University of Utah

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02
Study Completion Date2026-05

Study Record Updates

Study Start Date2025-02
Study Completion Date2026-05

Terms related to this study

Keywords Provided by Researchers

  • habit reversal training
  • tics
  • tourette
  • tourette's disorder
  • Tourette syndrome
  • treatment for tics

Additional Relevant MeSH Terms

  • Tics
  • Tourette Disorder
  • Tourette Syndrome in Children
  • Tourette Syndrome in Adolescence